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ABSTRACT
RegulationSpotter is a web-based tool for the user-
friendly annotation and interpretation of DNA vari-
ants located outside of protein-coding transcripts
(extratranscriptic variants). It is designed for clini-
cians and researchers who wish to assess the po-
tential impact of the considerable number of non-
coding variants found in Whole Genome Sequenc-
ing runs. It annotates individual variants with un-
derlying regulatory features in an intuitive way by
assessing over 100 genome-wide annotations. Ad-
ditionally, it calculates a score, which reflects the
regulatory potential of the variant region. Its dichoto-
mous classifications, ‘functional’ or ‘non-functional’,
and a human-readable presentation of the underly-
ing evidence allow a biologically meaningful inter-
pretation of the score. The output shows key as-
pects of every variant and allows rapid access to
more detailed information about its possible role in
gene regulation. RegulationSpotter can either anal-
yse single variants or complete VCF files. Variants
located within protein-coding transcripts are auto-
matically assessed by MutationTaster as well as
by RegulationSpotter to account for possible intra-
genic regulatory effects. RegulationSpotter offers
the possibility of using phenotypic data to focus on
known disease genes or genomic elements interact-
ing with them. RegulationSpotter is freely available
at https://www.regulationspotter.org.
INTRODUCTION
In the general search for disease mutations, Whole Genome
Sequencing (WGS) is steadily gaining ground. In contrast
to Whole Exome Sequencing (WES), it also detects vari-
ants within promoters and enhancers, while reducing en-
richment problems and artefacts (1). However, the nature
and sheer number of variants discovered by WGS pose new
challenges for the identification of causal mutations. Whilst
the prediction of the effect of variants leading to amino acid
substitutions is now relatively straightforward, non-coding
variants are much harder to classify. At present, several pre-
diction tools such as GWAVA (2), CADD (3), deepSEA (4),
or the REMM score of Genomiser (5) are able to assess ‘ex-
tratranscriptic’ variants located outside of transcripts. A re-
cent publication by Rojano and colleagues summarises cur-
rently available prediction tools with their advantages and
limitations (6). One major drawback of these programs is
that they provide results in the form of scores instead of bi-
ologically meaningful annotations that are critical for our
target audience, clinicians and life scientists. This is inher-
ently problematic since the expertise of the latter groups is
indispensable for the determination of the molecular cause
of inherited diseases (7,8). A recent study by Shyr et al.
(9) concluded that the ‘successful adoption of a clinical
WES/WGS system is heavily dependent on its ability to
address the diverse requirements of specialists in distinct
healthcare domains’. They thus propose software interfaces
specifically tailored to the needs of different professional
groups. Most clinicians prefer graphical interfaces and the
limiting of the displayed data to those particular features
which are most relevant to their questions (9). In addition,
these features must be represented in a meaningful, com-
prehensive fashion, not as a battery of raw scores. Tools
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such as Ensembl’s Variant Effect Predictor (10) (VEP) or
RegulomeDB (11) offer a higher degree of human read-
able annotation, but do not allow dedicated filtering strate-
gies focused on phenotypic features or candidate genes. We
have therefore developed RegulationSpotter, a web-based
and user-friendly software for the rapid and convenient an-
notation and analysis of extratranscriptic DNA variants. In
a novel approach to analysing regulatory variants, we fo-
cus on the human-readable presentation of the underlying
biological data combined with an annotation-based score,
thereby rendering RegulationSpotter usable to those clin-
icians and researchers who lack bioinformatics skills but
who still strive to make sense of large sequencing data on
their own.
METHODS
Software implementation and data integration
RegulationSpotter runs on a 48-CPU system with 512 GB
RAM under Linux (CentOS 6). All data used by Regula-
tionSpotter are physically integrated and stored in a Post-
greSQL 9.5 database. RegulationSpotter program scripts
are written in Perl (version 5.10) and run on an Apache 2.2
web server with HTTPS web protocol. All user interfaces
are written in HTML with usage of JavaScript functions
and were thoroughly tested for the Firefox browser under
Linux, MacOS andMicrosoft Windows. Additional testing
involves Google Chrome and Safari. We employ TORQUE
(version 4.2) as our job scheduling system.
Training data
We set up two different data sets with extratranscriptic vari-
ants (SNVs and InDels) to deduce the biological and clini-
cal relevance of integrated regulatory features. The positive
data set (P1) contains 457 extratranscriptic disease muta-
tions (tag DM) from the Professional version of HGMD
(HGMDPro®, build 2018/1) (12) and theGenomiser pub-
lication (5). The negative data set (N1) comprises 8,000
randomly chosen common polymorphisms from the 1000
Genomes Project (13), all present in the homozygous state
in more than 10 individuals. Further information about the
generation of the data sets is given in the Supplementary
Material.
RESULTS
RegulationSpotter is aimed at clinicians and life scientists
In order to address the need for a clinician-friendly soft-
ware aimed at the analysis of deep sequencing projects, we
have developed RegulationSpotter. Our tool is web-based
and performs a comprehensive annotation of single base ex-
changes and short InDels. RegulationSpotter accepts VCF
4.1 files without any size limitation (e.g. complete WGS
runs) and provides an in-depth annotation of all variants
chosen to be analysed.
Table 1 summarises the functionalities of Regula-
tionSpotter and comparable tools (see Discussion for de-
tails).
RegulationSpotter integrates more than 100 distinct genomic
features
RegulationSpotter integrates data on gene regulation from
different publicly available resources (122 different features)
to annotate extratranscriptic variants. We include various
tracks from the Ensembl Regulatory Build (14) version
37/91, such as promoters, promoter flanking regions, en-
hancers, CTCF binding sites, transcription factor binding
sites (TFBS) and open chromatin regions. Apart from inte-
grating these precomputed regulatory features, we further
processed and merged available annotation tracks to gen-
erate customised, refined annotations (e.g. promoters with
epigenetic marks which suggest activity detected in at least
three cell lines). The Ensembl Regulatory Build also com-
prises enhancers from VISTA (15) and promoter and TSS
(transcription start site) annotations from the FANTOM5
project (16). In order to link distant modifiers such as en-
hancers to promoters, we use genome-wide interaction data
from Hi-C (17) and ENCODE (18,19) 5C (20) experiments
and FANTOM5 enhancer-TSS associations analysed with
CAGE (21). Moreover, the degree of evolutionary conser-
vation via PhastCons (22) and PhyloP (23) is also included
(see Table S1 in the Supplementary Material for details on
integrated data).
RegulationSpotter facilitates the analysis of Whole Genome
Sequencing data
RegulationSpotter handles genotype data in VCF format
but can also analyse single variants on-the-fly. Single queries
are entered via chromosome, position, reference base and
altered base. In order to streamline the analysis of data from
WGS projects, the software determines for every variant
(SNV or InDel), whether it is located within a protein cod-
ing transcript or outside, i.e. extratranscriptic. Irrespective
of the chosen interface (single variant or VCF file analysis),
variants within protein coding transcripts are automatically
analysed by MutationTaster (24), our previously published
software to predict the disease potential of intragenic vari-
ants, as well as byRegulationSpotter, in order to account for
a potential intratranscriptic regulatory impact. Extratran-
scriptic variants are analysed solely by RegulationSpotter.
Figure 1 depicts the numerous functional aspects covered
by RegulationSpotter andMutationTaster, which can all be
assessed in a single analysis run. In VCF filemode, users can
initially restrict the analysis to candidate genes or regions,
thereby selecting only those variants, which either reside
within these genes, their promoter regions, or within inter-
acting cis-regulatory regions. In addition, they can choose
to exclude variants found in population based databases
(currently 1000G and ExAC) with user-specified counts of
carriers and/or homozygous carriers. This drastically re-
duces the run time to about 6–12 hours per genome (de-
pending on server load). Submitted variants (along with the
genotype and coverage) and the analysis results are stored in
a database. Variants, which have already been analysed, are
not re-analysed if uploaded in another project, saving more
time. Re-analysis of the same genome, e.g. after a change in
the alignment or variant calling pipeline, usually takes less
than 10 minutes.
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Table 1. Overview of RegulationSpotter core features and comparable tools. (1) Helpful in this context means any effort to prepare and present the results
in a structured or graphical way that helps the user to understand the numerous annotations. (2) This means that all types of variants (known, unknown,
SNVs, short InDels) found by Whole Genome Sequencing can be submitted and analysed in a single run and without the need for prior processing of the
format or the file size. (3) This refers to the possibility to restrict the analysis to variants residing in candidate genes or their associated regulatory elements
such as promoters and distant enhancers or silencers. () CADD scores are only available for a limited selection of short InDels
After the analysis, an interface is displayed to select vari-
ants, export the data or delete a project (see Supplementary
Figure S2). It also gives information on the number of vari-
ants that were processed and provides access to the variants
excluded. Results can then be downloaded as simple text
files, or watched directly online.
To reduce the number of variants to be further inspected,
users can easily narrow them down to those located in user-
defined genomic regions or affecting candidate genes. These
candidate genes can either be enteredmanually or suggested
by RegulationSpotter if the user enters the patient’s phe-
notype, as clinical diagnoses (via OMIM (25) or OrphaNet
(26)) or by their clinical symptoms (via the Human Pheno-
type Ontology, HPO (27)).
A summary table provides a quick overview of the vari-
ants meeting the display criteria (Figure 2 and Supplemen-
tary Figure S3). The most relevant functional aspects are
displayed in a colour-coded matrix, either as on/off for di-
chotomic elements (e.g. location within a promoter) or as a
colour grade for continuous and discontinuous values (such
as conservation or allele frequencies). Hyperlinks guide the
user to detailed per-variant results (see Supplementary Fig-
ure S4) showing key aspects of every variant and allowing
rapid access to more detailed information about its possi-
ble role in gene regulation. By grouping different regulatory
annotations together by their probable biological role, Reg-
ulationSpotter offers intuitive access to the sometimes com-
plex regulatory element landscape.Users can easily generate
hyperlinks to RegulationSpotter results, RegulationSpotter
can therefore also be employed as a variant visualization
tool in other software. Analysis results are stored in our
database for at least three weeks, but can also be deleted
earlier or stored longer upon the user’s request.
Phenotypic information can help to find the disease mutation
Apart from directly entering candidate genes or regions to
filter variants before or after analysis, users can in the vari-
ant selection interface also specify a clinical diagnosis, dis-
ease (viaOMIMorOrphanet) or clinical features (viaHPO)
in order to restrict the displayed variants to those residing in
disease- or symptom-related candidate genes. The interface
offers a text area with autocompletion functionality where
entries from OMIM, Orphanet or the HPO automatically
pop up while typing in a disease or symptom. Afterwards, a
list of associated candidate genes is shown. Users can adjust
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Figure 1. Overview of features that can be assessed in a single RegulationSpotter VCF analysis run. Depending upon a variant’s localisation, different
aspects are analysed either by RegulationSpotter or MutationTaster. (*) It should be noted that intragenic variants are always additionally analysed by
RegulationSpotter to account for the possible regulatory effects of e.g. non-coding variants. UTR: untranslated region; CDS: coding sequence; TSS:
transcription start site; NMD: nonsense-mediated mRNA decay.
a threshold to apply a more or less rigid filtering. Variants
within distant regulatory regions such as enhancers are also
displayed if the regulatory element is linked to a candidate
gene. The connection between distant regulatory elements
and associated genes is drawn from HiC and 5C data (see
Supplementary Material).
Human-readable evidence for the disease potential of a vari-
ant
The results page for a single variant provides details about
genomic features present within the region in which the
variant is located. Various annotations retrieved from dif-
ferent sources are grouped depending on their assumed
role in gene regulation (e.g. promoter and enhancer fea-
tures), in order to facilitate their interpretation. Hyperlinks
to external sources such as the Ensembl Genome Browser
(28), the ZENBU genome browser (29) or our web-based
tool ePOSSUM (30) (for studying the effects of variants
in TFBS) allow quick and easy deeper investigation. Data
about genomic interactions are additionally visualised in a
plot which shows involved genes or transcripts as well as
genomic loci associated with these genes and where on a
genomic scale these are located (see Supplementary Figure
S5).
Since regulatory information is mostly available for dif-
ferent cell types, we grouped them together into more in-
tuitive colour-coded tissue groups, so that researchers can
easily decide if a variant has annotations in their tissue of
interest. Although much information is presented, the de-
sign allows clinicians and researchers to obtain a rapid yet
thorough understanding of a variant’s localisation, genomic
context, and possible role in regulating disease-relevant
genes. By offering annotations from amultitude of different
data sources, it saves users from having to manually collect
this information on their own.
Indication of functional relevance of extratranscriptic regions
Apart from annotating variants, RegulationSpotter pro-
vides a score (region score), which gauges the functional rel-
evance of the region within which a given variant is located.
This score is generated using a subset of 77 features, which
showed discriminative power in a testset of known extra-
transcriptic disease mutations and putatively neutral poly-
morphisms (see Methods and Supplementary Material for
test set assembly and feature selection). In contrast to sim-
ilar scores generated by other programs, the region score is
not generated by a classifier. Instead of applying machine-
learning algorithms and risk overfitting to the low number
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Figure 2. Screenshot of the colour-coded results matrix. Variants chosen to be displayed are organised in a summary table (left part) and in a colour-coded
matrix (right part) in order to allow the rapid overview of every variant. Users can follow hyperlinks to study every variant in further detail.
of known extratranscriptic disease mutations, we carried
out an initial feature selection and weight determination
based on current biological knowledge. We then adjusted
the region score on the basis of our preconception as to the
effect of the different features and their relative risk ratio
of appearing in either a set of 457 extratranscriptic func-
tional variants from HGMD (12) and the Genomiser pub-
lication (data set P1) or in 8,000 common polymorphisms
from the 1000G (data set N1; see Supplementary Figure S1
for relative risks). This strategy allowed us to limit score-
relevant features to those likely to be most meaningful in
terms of their biological role (see Supplementary Tables S1
and S2 for exact relative risks and feature weights). To fa-
cilitate the interpretation of the region score, we provide a
colour-coded translation of the score and the functional rel-
evance of the region. Blue indicates that the region is prob-
ably not functional in terms of gene regulation, whereas red
encodes likely functional regions. Additionally, we distin-
guish between poor evidence (pale colour) and strong evi-
dence (strong colour). Knowledge about the functional an-
notation can help to deduce the relevance of a variant in an
intuitive way.However, owing to the relatively small number
of known disease mutations that were available for train-
ing, we do not assess the effect of the variant itself, only
the likely relevance of the genomic region. Intragenic vari-
ants, which can be analysed by MutationTaster, are classi-
fied as disease causing or polymorphism. Known polymor-
phisms found in the homozygous state and disease muta-
tions from ClinVar are automatically recognised and clas-
sified. The Supplementary Material provides further infor-
mation on region score generation and integrated features.
DISCUSSION
RegulationSpotter is a web-based tool for the convenient
and streamlined analysis and interpretation of DNA vari-
ants from high-throughput sequencing projects. Since it is
intended to aid clinicians and life scientists in the interpre-
tation of complex WGS data, our main focus lies on the us-
ability and comprehensive presentation of the results. Our
aim has been to offer a broad range of regulatory anno-
tations while also supporting the user in making sense of
the presented data. The region score can help in sorting
variants according to the amount of regulatory knowledge
about the region they are located in. By allowing dynamic
post-analysis filtering for candidate genes and regions, re-
searchers can incorporate their clinical or biological knowl-
edge, which is indispensable in the process of identifying
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likely disease variants. With the combination of (a) offering
extensive annotation of complete VCF files from WGS, (b)
easily understandable user interfaces and presentation of re-
sults and (c) taking into account previous knowledge about
biological or disease-related questions, RegulationSpotter
stands apart from classical effect prediction tools (see Table
1). The different aspects featured in the table are in our opin-
ion highly relevant for clinicians and life scientists. They
help to assess the possible involvement of a regulatory vari-
ant in the clinical phenotypes of their patients. For example,
a presentation of results that goes beyond the simple list-
ing of annotated features is desirable to facilitate our under-
standing of the numerous annotations. This can be achieved
by graphical display or the grouping of different features in
the context of their role in gene regulation. A transparent
score facilitates understanding of the assumed functional
impact of a variant. The possibility to connect clinical fea-
tures and diseases to candidate genes, and the subsequent
search for variants affecting these, takes into account the
clinical expertise of physicians. Simple interfaces and web-
based access are crucially important in a clinical setting
where software oftenmust not be installed locally. The anal-
ysis of all types of variants, going beyond SNVs, guarantees
a seamless analysis with reduced effort. Taken together, we
consider that RegulationSpotter offers a unique combina-
tion of services relevant to our target audience.
We developed the software in an iterative manner and in
close collaboration with users, thereby maximising adap-
tion to their needs. By accessing 122 different annotation
features from a multitude of sources, RegulationSpotter
spares the user from having to collect data on their own and
significantly facilitates the in-depth study of potential regu-
latory variants. Instead of randomly displaying all available
annotations, we group the single features together depend-
ing on their assumed role in gene regulation. Promoters and
enhancers are key regulatory elements in gene expression
(reviewed in (31–34)). Typical epigenetic marks for active
promoters are trimethylation ofH3K4 (H3K4me3) (35) and
hypersensitivity to DNaseI (DNaseI hypersensitivity sites,
DHS) (36,37), which are both largely invariant across dif-
ferent cell types (37,38). Active enhancers are characterised
bymonomethylation ofH3K4 (H3K4me1) (35), acetylation
of H3K27 (H3K27ac) (39) and hypersensitivity to DNaseI
(36,37) and are highly specific for different cell types (38).
Moreover, these marks have a significant predictive poten-
tial in terms of the functional relevance of extratranscriptic
DNA sequence variants (40,41). In addition to integrating
these precomputed multicell regulatory features from the
Ensembl Regulatory build, which are rather broadly anno-
tated due to their cell type-unspecific nature, we highlight
H3K4me3 modifications and DHSs overlapping in at least
three cell types as relevant custom annotation for active pro-
moters. Enhancers are denoted as either active or poised in
certain cell lines / types.
To facilitate further investigations, RegulationSpotter
also provides hyperlinks, e.g. to our web-based tool ePOS-
SUM for studying the effects of variants in TFBS or to our
candidate gene search engine GeneDistiller (42). To make
maximum use of their own knowledge, users can select dis-
eases and symptoms from OMIM, Orphanet and the HPO
to automatically restrict their results to those variants re-
siding in genes or regulatory elements known to cause the
disease or phenotype in question. The degree of matching
between gene and phenotype does not however affect the
scoring. The implementation of a machine-learning algo-
rithm that takes into account phenotypic information is
currently hampered by the paucity of solved cases with a
known disease-causing mutation and comparably deep and
reliable phenotyping. With advances in the area of patient
phenotyping and digital health recording, these shortcom-
ings may be overcome in the future.
RegulationSpotter offers annotation and a sorting func-
tionality based on the amount of annotation known for
a certain genetic locus. It does not offer prediction of the
functional relevance of a variant itself. The low number of
functionally validated extratranscriptic disease mutations,
most of which affect highly conserved nucleotides, may not
truly reflect the majority of extratranscriptic disease muta-
tions. These training mutations mostly exert a strong effect
and do not reliably model lesser effects whichmight become
deleterious in synergy with other variants (43). The lack of
representative training data is also due to the fact that time-
and cost-intensive validation studies such as mouse models
are usually only conducted for variants with a clear indica-
tion of disease relevance, e.g. deletion of a TFBS or very
high conservation. We therefore recommend critically as-
sessing the functional evidence underlying any scores and
for this reason offer comprehensive annotations in the first
place and only as an addition the region score. We display
all the integrated data and the respective sub-scores used to
generate it, thereby allowing the user to understand the re-
sults without the need for further research on background
information. Similar to the output of comparable programs,
the region score should not be treated as an absolute crite-
rion for the disease potential of a given variant, but rather
should be used as an indicator to prioritize extratranscriptic
variants according to their regulatory potential.
Asmentioned, RegulationSpotter evaluates variants only
based on positional effects, i.e. the available annotation at
the locus, rather than considering the nature of the change
itself. This is, however, also a common limitation of other
available programs. It is known that single base exchanges
or small InDels in promoter regions may lead to altered
gene expression and ultimately to disease (44,45). However,
to our knowledge, there is so far no systematic study, which
investigated where, within the promoter, disease mutations
preferentially reside.
It remains unclear how the exact nature of aDNA change
within enhancer regions interferes with gene regulation. Re-
cent studies in mice addressed the question whether mam-
malian enhancers typically act in an additive manner or
if the regulation of one gene by several enhancers might
serve as a kind of redundancy backup (46). Owing to en-
hancer redundancy, which appears to be a widespread fea-
ture of mammalian genomes, deleterious consequences due
to changes in only a single enhancer may be prevented.
On the other hand, there are so-called ultraconserved en-
hancers, where variation to just one single enhancer may
result in a clear phenotype (47). A recent study raised
the point that the still fragmentary knowledge and limited
amount of representative training datamight currently limit
the performance of reliable algorithms that are capable of
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predicting the outcome of all kinds of regulatoryDNAvari-
ant (43). More data and deeper annotation are needed for
us to be able to deduce general rules about the functional
consequences of variants located in distant regulatory re-
gions.
With its focus on user-friendliness and comprehensible
presentation of integrated data, RegulationSpotter can help
to reduce the number of variants that require follow-up in-
vestigation, and we believe that it will become a valuable re-
source in human genomics research. As new knowledge and
more data emerge, we shall be able to continually update
and extend the data used by RegulationSpotter and opti-
mise the computation of the region score to offer even better
interpretation and annotation of extratranscriptic variants
in the future.
DATA AVAILABILITY
RegulationSpotter is freely available at https:
//www.regulationspotter.org. No login is required. We
provide a thorough documentation along with a tutorial on
our website. With simple hyperlinks (position and alleles),
RegulationSpotter can easily be used as a downstream
application for WGS analysis.
RegulationSpotter accepts single-sample VCF files in
VCF 4.1 format as well as single variants in VCF-like no-
tation. Analysis of a WGS project with 3.5 million variants
takes ∼4–12 h, depending on the server load. This length
of time can be drastically reduced by filtering out com-
mon polymorphisms or confining the analysis to candidate
genes, their promoters and interacting regions. These op-
tions are available in our upload interface. Uploaded data
are available only via a unique secret URL, which is dis-
played to our users during the upload process. We strongly
recommend to zip large VCF files prior to upload to reduce
the upload time, which might be long, depending on the in-
ternet speed (e.g. the upload of 1GB at an upload speed of
5 Mbps takes approximately 30 min). The data are auto-
matically deleted from the webserver after 3 weeks unless
users actively delete their project or request an extension by
E-mail.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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